HALO logo
halo search icon
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
FDMT · NAS

4D Molecular Therapeutics, Inc.

US$8.69

Price Arrow0.22 (2.60%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BullishEngulfing Bullish (Realtime)HALO AllHALO Consensus ValueHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

4D Molecular Therapeutics, Inc. Overview

FDMT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About FDMT

icon

Telephone

1.510.505.2680

icon

Address

Suite 455, 5858 Horton Street, Emeryville, CA 94608

Description

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

FDMT Price Chart

Key Stats

Market Cap

US$442.78M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.37 - 12.34

Trade Value (12mth)

US$1,802,522.00

1 week

-7.43%

1 month

-13.57%

YTD

15.71%

1 year

135.28%

All time high

55.11

Key Fundamentals

EPS 3 yr Growth

-27.20%

EBITDA Margin

-178.30%

Operating Cashflow

-$109m

Free Cash Flow Return

-20.80%

ROIC

-26.70%

Interest Coverage

0.00

Quick Ratio

9.40

Other Data

Shares Outstanding (Fully Diluted)

68m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

FDMT Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

FDMT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.58-2.98-2.42locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.58-2.98-2.42locklocklock
Growth
%locklocklocklock22.4-15.718.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of 4D Molecular Therapeutics, Inc. (FDMT:NAS)?
Halo FAQ
The current share price of 4D Molecular Therapeutics, Inc. (FDMT:NAS) is USD$8.69.
What is the 52-week high share price for 4D Molecular Therapeutics, Inc. (FDMT:NAS)?
Halo FAQ
The 52-week high share price for 4D Molecular Therapeutics, Inc. (FDMT:NAS) is USD$12.34.
What is the 52-week low share price for 4D Molecular Therapeutics, Inc. (FDMT:NAS)?
Halo FAQ
The 52-week low share price for 4D Molecular Therapeutics, Inc. (FDMT:NAS) is USD$3.37.
What is the dividend yield for 4D Molecular Therapeutics, Inc. (FDMT:NAS)?
Halo FAQ
4D Molecular Therapeutics, Inc. (FDMT:NAS) does not pay a dividend.
What was 4D Molecular Therapeutics, Inc. (FDMT:NAS) last dividend payment?
Halo FAQ
4D Molecular Therapeutics, Inc. (FDMT:NAS) does not pay a dividend.
What is the franking level for 4D Molecular Therapeutics, Inc. (FDMT:NAS)?
Halo FAQ
4D Molecular Therapeutics, Inc. (FDMT:NAS) has a franking level of 0.00%.
In which sector is 4D Molecular Therapeutics, Inc. (FDMT:NAS) classified?
Halo FAQ
4D Molecular Therapeutics, Inc. (FDMT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.